Chromoanagenesis and Cancer: Mechanisms and Consequences of Localized, Complex Chromosomal Rearrangements
Overview
Molecular Biology
Authors
Affiliations
Next-generation sequencing of DNA from human tumors or individuals with developmental abnormalities has led to the discovery of a process we term chromoanagenesis, in which large numbers of complex rearrangements occur at one or a few chromosomal loci in a single catastrophic event. Two mechanisms underlie these rearrangements, both of which can be facilitated by a mitotic chromosome segregation error to produce a micronucleus containing the chromosome to undergo rearrangement. In the first, chromosome shattering (chromothripsis) is produced by mitotic entry before completion of DNA replication within the micronucleus, with a failure to disassemble the micronuclear envelope encapsulating the chromosomal fragments for random reassembly in the subsequent interphase. Alternatively, locally defective DNA replication initiates serial, microhomology-mediated template switching (chromoanasynthesis) that produces local rearrangements with altered gene copy numbers. Complex rearrangements are present in a broad spectrum of tumors and in individuals with congenital or developmental defects, highlighting the impact of chromoanagenesis on human disease.
Extrachromosomal DNA: Molecular perspectives in aging and neurodegenerative diseases.
Ma Y, Xia Y, Karako K, Song P, Hu X Intractable Rare Dis Res. 2024; 13(4):251-254.
PMID: 39628626 PMC: 11609041. DOI: 10.5582/irdr.2024.01058.
The Spiral Model of Evolution: Stable Life Forms of Organisms and Unstable Life Forms of Cancers.
Kasperski A, Heng H Int J Mol Sci. 2024; 25(17).
PMID: 39273111 PMC: 11395208. DOI: 10.3390/ijms25179163.
Prognostic and Potential Therapeutic Roles of PRKDC Expression in Lung Cancer.
Xiong J, Deng C, Fu Y, Tang J, Xie J, Chen Y Mol Biotechnol. 2024; .
PMID: 39044064 DOI: 10.1007/s12033-024-01209-3.
Cancer fusion transcripts with human non-coding RNAs.
Mohammad T, Zolotovskaia M, Suntsova M, Buzdin A Front Oncol. 2024; 14:1415801.
PMID: 38919532 PMC: 11196610. DOI: 10.3389/fonc.2024.1415801.
Tracking Karyotype Changes in Treatment-Induced Drug-Resistant Evolution.
Ye J, Heng H Methods Mol Biol. 2024; 2825:263-280.
PMID: 38913315 DOI: 10.1007/978-1-0716-3946-7_15.